Cargando…

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine

Hydroxyurea (HU) alone has the potential to prevent one out of every three deaths due to sickle cell disease (SCD) and almost all forms of disabilities caused by SCD. However, in Tanzania, only one out of every six registered SCD patients in the SPARCO-Tanzania Sickle Cell Cohort use HU. We conducte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilonzi, Manase, Mlyuka, Hamu, Jonathan, Agnes, Tutuba, Hilda, Chirande, Lulu, Rugajo, Paschal, Kida, Irene, Balandya, Emmanuel, Makani, Julie, Sirili, Nathanael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2022
Materias:	Policy Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457563/ https://www.ncbi.nlm.nih.gov/pubmed/37638133 http://dx.doi.org/10.12688/f1000research.111300.1

Ejemplares similares

The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2022)

Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators
por: Mlyuka, Hamu J., et al.
Publicado: (2022)

Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania
por: Mutagonda, Ritah F, et al.
Publicado: (2022)

Healthcare Workers’ Knowledge and Resource Availability for Care of Sickle Cell Disease in Dar es Salaam, Tanzania
por: Jonathan, Agnes, et al.
Publicado: (2022)

The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study
por: Tutuba, Hilda J., et al.
Publicado: (2023)

Oxygen Saturation in Primary Teeth of Individuals With Sickle Cell Disease and Sickle Cell Trait
por: Wilson, Evarist Mulyahela, et al.
Publicado: (2022)

Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania
por: Tutuba, Hilda J., et al.
Publicado: (2022)

Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania
por: Ambrose, Emmanuela E, et al.
Publicado: (2023)

Level of knowledge among health care providers on preparation of injectable artesunate for treatment of severe malaria in public health facilities in Tanzania
por: Mikomangwa, Wigilya P., et al.
Publicado: (2019)

Level of medication self-management capacity among patients on ambulatory care exiting hospital pharmacy at Muhimbili National Hospital, Tanzania: a descriptive cross-sectional study
por: Mlyuka, Hamu, et al.
Publicado: (2019)

A decade since sulfonamide-based anti-malarial medicines were limited for intermittent preventive treatment of malaria among pregnant women in Tanzania
por: Marealle, Alphonce I., et al.
Publicado: (2018)

Unlawful dispensing practice of diazepam: a simulated client approach in community pharmacies in the north-west of Dar-es-Salaam region, Tanzania
por: Mikomangwa, Wigilya Padili, et al.
Publicado: (2019)

Adherence to Antiretroviral Therapy Among HIV-Infected Clients Attending Opioid Treatment Program Clinics in Dar es Salaam, Tanzania
por: Kizindo, John, et al.
Publicado: (2022)

The magnitude of prescribing medicines by brand names at Muhimbili National Hospital, Tanzania
por: Kisamo, Ombeni, et al.
Publicado: (2020)

P108: ASSESSMENT OF HEALTHCARE WORKERS’ KNOWLEDGE AND RESOURCE AVAILABILITY FOR CARE OF SICKLE CELL DISEASE AT HEALTH FACILITIES IN DAR ES SALAAM, TANZANIA
por: Jonathan, A, et al.
Publicado: (2022)

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost
por: Costa, Enrico, et al.
Publicado: (2020)

Knowledge and participation in mass drug administration against lymphatic filariasis and soil-transmitted helminth infections among the community members in Dar es Salaam, Tanzania
por: Ngunyali, Diana A, et al.
Publicado: (2022)

Knowledge of use of antibiotics among consumers in Tanzania
por: Gabriel, Salvador, et al.
Publicado: (2021)

The Existence of High Bacterial Resistance to Some Reserved Antibiotics in Tertiary Hospitals in Tanzania: A Call to Revisit Their Use
por: Mikomangwa, Wigilya P, et al.
Publicado: (2020)

Utilization patterns of malaria chemoprophylaxis among Tanzanian children attending sickle cell clinic in Dar es Salaam tertiary hospitals
por: Ndegeulaya, Esther J., et al.
Publicado: (2019)

Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study
por: Kibanga, Wema, et al.
Publicado: (2023)

5610785 THE EFFICACY OF HEALTH EDUCATION INTERVENTION AND MATERNAL SCREENING ON KNOWLEDGE AND INFANT SCREENING FOR SICKLE CELL DISEASE AMONG PREGNANT WOMEN ATTENDING ANTENATAL CLINICS IN DAR-ES-SALAAM, TANZANIA
por: Tutuba, H.J., et al.
Publicado: (2023)

Reliability of visual assessment of neonatal jaundice among neonates of black descent: a cross-sectional study from Tanzania
por: Dionis, Ikunda, et al.
Publicado: (2021)

Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania
por: Sirili, Nathanael, et al.
Publicado: (2023)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

Determinants of misuse of antibiotics among parents of children attending clinics in regional referral hospitals in Tanzania
por: Mutagonda, Ritah F., et al.
Publicado: (2022)

Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica
por: Paintsil, Vivian, et al.
Publicado: (2023)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9mj41dnepi8hq90i93k11os6bi